To screen ETFs by asset class, performance, yield and more, check out the
Day after day -
crushin' it's 52 week high. Thumbs up!
Add a reply...
Latest StockTalks »
people get MRK breaking news and analysis by email alert.
Get email alerts on MRK »
Merck & Co Inc.
Get latest price
From other sites
Agenus Gains after Merck Extends Immuno-Oncology Ties - Analyst Blog
at Zacks.com (Jun 4, 2015)
Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog
at Zacks.com (Jun 2, 2015)
Merck Takes Aim at Gilead. Should You Worry?
at Investopedia (May 29, 2015)
Dow 30 Stock Roundup: GE May Divest Vehicle Management Unit, Merck's Keytruda Gets Favorable Opinion - Analyst Blog
at Zacks.com (May 29, 2015)
Merck : and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDA® (pembrolizumab)
at 4-traders.com (May 28, 2015)
Xignite quote data
© 2015 Seeking Alpha